Director, Medical Affairs Strategy (Prostate Cancer)

Sumitomo Pharma Co., Ltd. is a global pharmaceutical company based in Japan with key operations in the U.S. (Sumitomo Pharma America, Inc.), Canada (Sumitomo Pharma Canada, Inc.) and Europe (Sumitomo Pharma Switzerland GmbH) focused on addressing patient needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the U.S., Canada, and Europe, a diverse pipeline of early- to late-stage assets, and in-house advanced technology capabilities, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn.

Job Overview

The Director, Medical Strategy (Prostate Cancer) will be a key member of the Medical Affairs team reporting to the Executive Director, Medical Affairs Strategy.  

The job is responsible for developing the strategic direction and alliance management for the Prostate Cancer therapeutic area and set the strategy for both internal company programs and external facing interactions. This job will effectively lead and communicate with cross-functional team members to develop and execute the strategy.  The role will also collaborate closely with Commercial leadership, as appropriate, on strategic initiatives and advance patient advocacy efforts to ensure that Medical Affairs activities align with patient focused programs.

Job Duties and Responsibilities

• Develops and aligns Medical Affairs strategic plans with brand strategic imperatives based on external engagement, MSL/cross functional input and impactful insights, supporting data generation, and data communication, education and awareness stakeholders.
• Serve as a Medical Strategy lead for the Pfizer alliance for Prostate, ensuring coordination and alignment of all Medical Affairs activities and budget within SMPA and with alliance partners.
• Oversee the strategy and development of Medical Affairs plans and scientific platforms.
• Ensure cross-functional medical alignment with the US Field Medical team, Medical Communications & Operations, RWE & HEOR and ex-US colleagues.
• Direct the implementation of plans that will be executed through multi-modal medical education channels, including publications, presentations, congresses, advisory boards, CME, medical symposia and other channels.
• Oversee the development and implementation of detailed scientific Publication Plans.
• Work with cross functional team to develop and execute Medical Advisory Board Plan.
• External engagement and maintain a highly visible role during exchanges within the medical/scientific community to develop close relationships with a group of scientific key opinion leaders.
• Work closely with the commercial organization to bring the medical perspective to commercial strategies and tactics, aligning with Marketing & Market Access to collaborate on the most efficient and effective ways for office and field forces to work together.
• Partner with the Research & Development organization for ongoing and post- Represent the Medical Affairs department on the lifecycle team for WH to provide Medical Affairs input to R&D.
• Define and attend relevant medical and scientific conferences to support speakers and presenters, ensure the success of publication/communication goals, and participate in the collection and reporting of competitive intelligence within company guidelines.
• Provide input into Medical Education program.
• Provide strategy and oversight for the development of a supportive US Investigator Initiated Study and Collaborative Research program.
• Provide detailed and compliant medical review and approval of external resources, communications, and publications – ensuring medical accuracy, relevance, and fair-balance.
• Develops and oversees Medical Affairs annual operating budget.
• Manages direct reports (if assigned).
• Ensures that all interactions and activities in the US adhere to corporate and healthcare compliance guidance in all activities, including those related to clinical trials, scientific interactions with internal and external g